Detailed Information

Cited 0 time in webofscience Cited 43 time in scopus
Metadata Downloads

Diabetes mellitus mitigates cardioprotective effects of remifentanil preconditioning in ischemia-reperfused rat heart in association with anti-apoptotic pathways of survival

Authors
Kim H.S.Cho J.E.Hwang K.C.Shim Y.H.Lee J.H.Kwak Y.L.
Issue Date
2010
Keywords
Diabetes mellitus; Ischemia-reperfusion; Remifentanil
Citation
European Journal of Pharmacology, v.628, no.1-3, pp 132 - 139
Pages
8
Indexed
SCI
SCIE
SCOPUS
Journal Title
European Journal of Pharmacology
Volume
628
Number
1-3
Start Page
132
End Page
139
URI
https://scholarworks.korea.ac.kr/kumedicine/handle/2020.sw.kumedicine/15500
DOI
10.1016/j.ejphar.2009.11.032
ISSN
0014-2999
1879-0712
Abstract
Diabetes mellitus has been known to mitigate ischemic or pharmacologic preconditioning in ischemia-reperfusion injuries. Remifentanil is a widely used opioid in cardiac anesthesia that possesses a cardioprotective effect against ischemia-reperfusion. We evaluated whether diabetes affected remifentanil preconditioning induced cardioprotection in ischemia-reperfusion rat hearts in view of anti-apoptotic pathways of survival and Ca2+ homeostasis. Streptozotocin-induced, diabetic rats and age-matched wild-type Sprague-Dawley rats were subjected to a left anterior descending coronary artery occlusion for 30 min followed by 1 h of reperfusion. Each diabetic and wild-type rat was randomly assigned to the sham, ischemia-reperfusion only, or remifentanil preconditioning group. Myocardial infarct size, activities of ERK1/2, Bcl2, Bax and cytochrome c, and gene expression influencing Ca2+ homeostasis were assessed. Remifentanil preconditioning significantly reduced myocardial infarct size compared to ischemia-reperfusion only in wild-type rats but not in diabetic rats. Remifentanil preconditioning increased expression of ERK1/2 and anti-apoptotic protein Bcl-2 and decreased expression of pro-apoptotic proteins, Bax and cytochrome c, compared to ischemia-reperfusion only in wild-type rats. In diabetic rat hearts, however, remifentanil preconditioning failed to recover the phosphorylation state of ERK1/2 and to repress apoptotic signaling. In addition, diabetes minimized remifentanil induced modulation of abnormal changes in sarcoplasmic reticulum genes and proteins in ischemia-reperfusion rat hearts. In conclusion, diabetes mitigated remifentanil induced cardioprotection against ischemia-reperfusion, which might be associated with reduced recovery of the activities of proteins involved in anti-apoptotic pathways including ERK1/2 and the abnormal expression of sarcoplasmic reticulum genes as a result of ischemia-reperfusion in rat hearts. © 2009 Elsevier B.V. All rights reserved.
Files in This Item
There are no files associated with this item.
Appears in
Collections
2. Clinical Science > Department of Anesthesiology and Pain Medicine > 1. Journal Articles

qrcode

Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.

Related Researcher

Researcher Cho, Jang Eun photo

Cho, Jang Eun
Anam Hospital (Department of Anesthesiology and Pain Medicine, Anam Hospital)
Read more

Altmetrics

Total Views & Downloads

BROWSE